Annals of the Rheumatic Diseases, 0003-4967
Journal
Publications
- 2021
- Published
Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids
Adam Croft, Joana Campos, Amy Naylor, Angela Taylor, Myriam Chimen, , Gareth Lavery, Karim Raza & Rowan Hardy, Feb 2021, In: Annals of the Rheumatic Diseases. 80, 2, p. 250-260 11 p.Research output: Contribution to journal › Article › peer-review
- 2020
- Published
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics
Caroline Gordon, 25 Jun 2020, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Letter › peer-review
- Published
PERSPECTIVES ON APPROACHES TO PREDICT THE DEVELOPMENT OF RHEUMATOID ARTHRITIS: A QUANTITATIVE ASSESSMENT OF PATIENTS AND THEIR FIRST DEGREE RELATIVES
Gwenda Simons, , , Peter Nightingale, Karim Raza & M Falahee, 2 Jun 2020, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Abstract › peer-review
- Published
PREDICTING RHEUMATOID ARTHRITIS USING THE SYMPTOMS IN PERSONS AT RISK OF RHEUMATOID ARTHRITIS (SPARRA) QUESTIONNAIRE
M Falahee, , , , Karim Raza & , 2 Jun 2020, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Abstract › peer-review
- Published
SAT0186 Developing predictors of global BILAG treatment response in patients with Lupus Nephritis: more lessons from the Aspreva Lupus Management Study group (ALMS) data
2 Jun 2020, In: Annals of the Rheumatic Diseases. 79, Suppl 1, p. 1034-1035 2 p.Research output: Contribution to journal › Abstract › peer-review
- Accepted/In press
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Lorraine Harper, Apr 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Article › peer-review
- Published
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach
Caroline Gordon & 14 others, , Mar 2020, In: Annals of the Rheumatic Diseases. 79, 3, p. 356-362 7 p.Research output: Contribution to journal › Article › peer-review
- Accepted/In press
Disruptive Innovation in Rheumatology; New Networks of Global Public-Private Partnerships are Needed to Take Advantage of Scientific Progress
Christopher Buckley, 26 Feb 2020, (Accepted/In press) In: Annals of the Rheumatic Diseases. 79, 5Research output: Contribution to journal › Article › peer-review
- Published
Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care
Raymond Oppong, , , , , , , Sue Jowett, , , , , , , & , Feb 2020, In: Annals of the Rheumatic Diseases. 79, 2, p. 276-284 9 p.Research output: Contribution to journal › Article › peer-review
- Published
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
Benjamin Fisher & 2 others, , Jan 2020, In: Annals of the Rheumatic Diseases. 79, 1, p. 3-18 16 p., 216114.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Urine metabolic profile in rheumatoid arthritis development
Stephen Young & , 27 Jun 2019, In: Annals of the Rheumatic Diseases. 78, Suppl 2, p. 2129-2130 2 p.Research output: Contribution to journal › Abstract › peer-review
- Published
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Caroline Gordon, 29 Mar 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.Research output: Contribution to journal › Review article › peer-review
- Published
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
Lorraine Harper & , Mar 2019, In: Annals of the Rheumatic Diseases. 78, 3, p. 399-405Research output: Contribution to journal › Article › peer-review
- Published
Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data
Anuradhaa Subramanian, Nicola Adderley, , , , Lorraine Harper & Krishnarajah Nirantharakumar, Feb 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 261-269 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Current challenges in the development of new treatments for lupus
Caroline Gordon, , & , 12 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 729-735 7 p.Research output: Contribution to journal › Article › peer-review
- Published
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome
Saba Nayar, Joana Campos, , , David Gardner, , , , , , Christopher Buckley, Simon Bowman, , , , , Benjamin Fisher, , & Francesca Barone, 10 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 2, p. 249-260 12 p.Research output: Contribution to journal › Article › peer-review
- 2018
- Published
Low aspirin use and high prevalence of preeclampsia risk factors among pregnant women in a multinational SLE inception cohort
Caroline Gordon, 20 Dec 2018, In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Letter › peer-review
- E-pub ahead of print
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
Jennifer Marshall, , , , , Ilfita Sahbudin, , , , , , Karim Raza, Andrew Filer, Christopher Buckley, & , 14 Dec 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis
Adam Croft, , , , , , , Christopher Buckley, , , & , 30 Jul 2018, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.Research output: Contribution to journal › Article › peer-review
- Published